LCM
ARNA

Legato Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Legato Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,257
Closed -$495K – 355
2021
Q2 		$495K Buy
+7,257
New +$473K 0.07% 241

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Legato Capital Management's ARNA Position: Q3 2021 in Review

Legato Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2021, closing a stake of 7,257 shares — an estimated $495K sold.

Legato Capital Management first reported a position in ARNA in Q2 2021 and held it in 1 quarter. The position peaked at $495K in Q2 2021. 235 funds tracked by Wall St. Rank hold ARNA as of Q3 2021.

  • Legato Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
  • Legato Capital Management sold 7,257 Arena Pharmaceuticals Inc shares in Q3 2021, an estimated $495K.
  • Legato Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2021 and held it in 1 quarter.
  • Legato Capital Management's Arena Pharmaceuticals Inc position peaked at $495K in Q2 2021.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2021.

Based on Legato Capital Management's 13F filing for Q3 2021, filed 9 Nov 2021.